Clinical Trial Update: Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating switching from tenofovir disoproxil fumarate to besifovir dipivoxil maleate for hepatitis B treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Besifovir Dipivoxil Maleate (besifovir dipivoxil maleate)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Hepatitis B, Besifovir Dipivoxil Maleate | Phase 4 | Status: UNKNOWN